Cue Biopharma Inc
3.6301 - 4.05
2.18 - 5.12
Join Discuss about CUE with like-minded investors
Good day would you like to get cue banks course for almost nothing?
74 Replies 6 👍 14 🔥
$DG (-1.6% pre) Dollar General Delivers Mixed Results, Poor Profit Outlook. Blame Interest Rates. http://ooc.bz/l/123609 $MOMO (-4.8% pre) Hello Group Inc. Announces Unaudited Financial Results for the Fourth Quarter and Fiscal Year 2022 http://ooc.bz/l/123611 $JBL (+0.6% pre) Jabil stock gains after profit, revenue rise above expectations and full-year outlook is above forecasts http://ooc.bz/l/123613 $BEKE (+5.8% pre) KE Holdings Inc. Announces Fourth Quarter and Fiscal Year 2022 Unaudited Financial Results http://ooc.bz/l/123615 $SIG (+3.7% pre) Signet tops earnings estimates for Q4 and offers upbeat guidance http://ooc.bz/l/123619 $TITN (-9.1% pre) Titan Machinery Inc. Announces Results for Fiscal Fourth Quarter and Full Year Ended January 31, 2023 http://ooc.bz/l/123621 $ADBE (+5.5% pre) Adobe lifts profit forecast for fiscal 2023 and beats estimates on quarterly results http://ooc.bz/l/123623 $BRCC (+0.3% pre) BRC Inc. Reports Fourth Quarter and Full Year 2022 Financial Results http://ooc.bz/l/123625 $HLTH (-5.5% pre) Cue Health Reports Fourth Quarter and Full-Year 2022 Financial Results http://ooc.bz/l/123627 $FIVE (-3.1% pre) Five Below Stock Falls On Guidance; Dollar General Mixed On Revenue http://ooc.bz/l/123629 $FLNT (-17.5% pre) Fluent Announces Fourth Quarter and Full-Year 2022 Financial Results http://ooc.bz/l/123631 $GRWG (-10.3% pre) GrowGeneration Reports Fourth Quarter and Full Year 2022 Financial Results; Provides First Quarter and Full Year 2023 Guidance http://ooc.bz/l/123633 $ISPO (+2.0% pre) Inspirato Announces 2022 Results, CFO Succession Plan and Provides 2023 Guidance http://ooc.bz/l/123635 $LPSN (-46.8% pre) LivePerson stock plummets after surprise loss and revenue decline, as Medicare suspending reimbursements pending review http://ooc.bz/l/123622 $MGNX (+2.5% pre) MacroGenics (MGNX) Surpasses Q4 Earnings Estimates http://ooc.bz/l/123637 $PD (+5.2% pre) PagerDuty (PD) Surpasses Q4 Earnings and Revenue Estimates http://ooc.bz/l/123639 $PANL (+0.8% pre) Pangaea Logistics Solutions Ltd. Reports Record Financial Results for the Three Months and Year Ended December 31, 2022 http://ooc.bz/l/123641 $TBLT (-16.7% pre) Toughbuilt Industries Announces Fourth Quarter and Full Year 2022 Results http://ooc.bz/l/123643 $PATH (+15.4% pre) UiPath (PATH) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates http://ooc.bz/l/123645 $ZDGE (+8.8% pre) Zedge Announces Second Quarter Fiscal 2023 Results http://ooc.bz/l/123647 $ZTO (+2.7% pre) ZTO Express (Cayman) Inc. (ZTO) Surpasses Q4 Earnings and Revenue Estimates http://ooc.bz/l/123649
41 Replies 10 👍 10 🔥
By Rae Wee SINGAPORE (Reuters) - The dollar slid on Thursday after the U.S. Federal Reserve said it had turned a corner in the fight against inflation, giving markets a boost in confidence that the end of the central bank's rate-hike campaign was near. Investors took a dovish cue from Fed Chair Jerome Powell's remarks on Wednesday that "the disinflationary process has started" in the world's largest economy, although he also signalled that interest rates would continue rising and that cuts were not in the offing. The Fed's statement on Wednesday, which came after the conclusion of its two-day policy meeting, where policymakers agreed to raise rates by 25 basis points, marked the central bank's first explicit acknowledgment of slowing inflation. The dollar dived following Powell's remarks. Against a basket of currencies, the U.S. dollar index fell to a fresh nine-month low of 100.80 on Wednesday. It was last 0.07% down at 100.88, having ended more than 1% lower on Wednesday. "It was very much a sort of relief ... that there was nothing there to really seriously challenge the market's prevailing view," said Ray Attrill, head of FX strategy at National Australia Bank (OTC:NABZY) (NAB). "(Powell) said that rates are going to have to be restrictive for some time, but that doesn't dissuade the market from saying some time might be six months, rather than two years." The Aussie surged to an eight-month high of $0.7158 in early Asia trade on Thursday and last bought $0.7150, after rallying 1.2% in the previous session. The kiwi similarly hit a fresh eight-month peak of $0.65365, after jumping more than 1% on Wednesday. Against the Japanese yen, the dollar slid more than 0.5% to a session-low of 128.17. With the Fed out of the way, the stage is set for the European Central Bank (ECB) and the Bank of England (BoE) to announce their interest rate decisions later on Thursday. Expectations are for a 50 bp rise from each. The euro rose to a roughly 10-month peak of $1.1034 on Thursday and was last 0.3% higher at $1.1023, while sterling moved up 0.14% to $1.2392. "The risk is that we get a hawkish 50 from the ECB and a dovish 50 from the Bank of England. That might create some volatility," said NAB's Attrill. Euro zone inflation eased for the third straight month in January, data on Wednesday showed. But any relief for the ECB may be limited, as underlying price growth held steady and concerns have already been raised about the reliability of the figures. "In Europe, the inflation pressure remains very high despite the drop in energy prices," said Tareck Horchani, head of prime brokerage dealing at Maybank Securities. "We should see (the) ECB continue hiking interest rates until at least the end of Q1 2023." In the United States, Friday's nonfarm payrolls report will be the next test of the Fed's fight against inflation, though official statistics on Wednesday showed that job openings had unexpectedly risen in December, pointing to a still-tight labour market. Markets are now expecting the Fed funds rate to peak just under 4.9% by June, compared with earlier expectations of a peak of just below 5%.
44 Replies 15 👍 8 🔥
Hi everyone - hope you are having a good trading week. It's certainly been lively, with more to come as we move towards year end, which is great for trading, but as we also say, volatility can be your very good friend or your greatest enemy, so watch your risk and money management. Yesterday's market reaction to the FOMC was a great example, with the interest rate hike coming in as expected (priced in), plus a 'dovish' statement that kept the bulls happy. The press conference was an entirely different affair. Whether the result of mishearing a question or it was a deliberate ploy, Jay Powell delivered a very hawkish set of answers - cue markets to brake hard & reverse. This type of price action often happens after major releases - the BOE is up later & we have the NFP tomorrow, which is why capturing the fade can pay dividends. However, if you are still learning and perhaps nervous about trading in such volatile conditions, it can help to watch the price action, and where there is a press conference, listen to what is being said simultaneously. During the Powell presser, David & I picked up almost immediately when there was a shift in tone. Powell is actually quite transparent, which helps. The next best thing is to find a good resume of what went down & here I can suggest either Forexlive or if you want a more forensic analysis, check out FXMacroGuy on Twitter.
120 Replies 13 👍 6 🔥
And on cue, here comes Dan Niles on CNBC
89 Replies 14 👍 10 🔥
By Ann Saphir and Howard Schneider (Reuters) -Slowing U.S. inflation may have opened the door for the Federal Reserve to temper the pace of coming interest rate hikes, but policymakers left no doubt they will continue to tighten monetary policy until price pressures are fully broken. A U.S. Labor Department report Wednesday showing consumer prices didn't rise at all in July compared with June was just one step in what policymakers said would be a long process, with a red-hot job market and suddenly buoyant equity prices suggesting the economy needs more of the cooling that would come from higher borrowing costs. The Fed is "far, far away from declaring victory" on inflation, Minneapolis Federal Reserve Bank President Neel Kashkari said at the Aspen Ideas Conference, despite the "welcome" news in the CPI report. Kashkari said he hasn't "seen anything that changes" the need to raise the Fed's policy rate to 3.9% by year-end and to 4.4% by the end of 2023. The rate is currently in the 2.25%-2.5% range. To be sure, Kashkari is the Fed's most hawkish member; most of his 18 colleagues believe a little less policy tightening may be enough to do the trick to bring prices under better control. San Francisco Fed President Mary Daly, in an interview with the Financial Times, also warned it is far too early for the U.S. central bank to "declare victory" in its fight against inflation. However, Daly said that a half-percentage point rate rise was her "baseline" but did not rule out a third consecutive 0.75% point rate rise at the central bank's next policy meeting in September, according to the report. Calling inflation "unacceptably" high, Chicago Fed President Charles Evans said he believes the Fed will likely need to lift its policy rate to 3.25%-3.5% this year and to 3.75%-4% by the end of next year, in line with what Fed Chair Jerome Powell signaled after the Fed's latest meeting in July. Still, he said, the CPI report marks the first "positive" reading on inflation since the Fed began raising interest rates in March in increasing increments -- a quarter of a percentage point to start, then a half a point, and then three-quarters-of-a-percentage point in both June and July. After Wednesday's CPI report, traders of futures tied to the Fed's benchmark interest rate pared bets on a third straight 75-basis-point hike at its Sept. 20-21 policy meeting, and now see a half-point increase as the more likely option. Equity markets took a similar cue on hopes for a less aggressive central bank, with the S&P 500 rising 2.1%. Financial markets are currently pricing a top fed funds rate of 3.75% by year-end, with rate cuts to follow next year, presumably as policymakers move to counter economic weakness. Kashkari called that scenario unrealistic, and said Fed policymakers are "united" in their determination to bring inflation down to the Fed's 2% target. The risk of recession "will not deter me" from advocating for what's needed to do so, he said. DATA ON TAP For the Fed to scale back, fresh inflation data will need to confirm the idea that price increases are slowing. The consumer price index rose 8.5% in July from a year earlier, Wednesday's report showed. While that marked a drop from June's 9.1% rate, prices are still rising at levels not seen since the 1970s and early 1980s. Food prices in July were up 11% from the year before, devastating for lower income families in particular. For the moment, however, analysts focused on the fact that, after months in which accelerating price pressures pushed Fed policymakers to tighten credit conditions faster than at any time since the 1980s, inflation data finally surprised in the other direction. "The Fed needs a lot more evidence (of slowing inflation)... but this is a good start," said Karim Basta, chief economist with III Capital Management. Data on August consumer inflation will be released on Sept. 13, the week before the Fed meets, and given recent trends in energy and some other prices the report "should also be friendly to the disinflation path and should make a 50 basis point hike the preferred option." Still, the Fed's battle with high inflation is far from over. The core consumer price index - which strips out volatile gas and food prices and is seen as a better predictor of future inflation - rose 0.3% from June and 5.9% from a year earlier. The Fed targets 2% inflation based on a different index that is rising at a lower, but still high, rate of more than 6%. An alternative measure of consumer prices compiled by the Cleveland Fed, known as the Median Consumer Price Index and considered a good view of the breadth of prices pressures in the economy, rose 6.3% on an annual basis in July, compared to 6% in June. "Overall, prices remain uncomfortably high," wrote High Frequency Economics' Rubeela Farooqi, who stuck with her call for a 75-basis point rate hike next month. "Coupled with strength in job growth and wages, the data support the case for another aggressive rate hike in September."
81 Replies 10 👍 6 🔥
right, I thought the same thing... but got that cue after I was in, but definitely I forgot to check that box before jumping in
114 Replies 7 👍 14 🔥
right on cue. BULLISH MARKETS
47 Replies 7 👍 15 🔥
By Huw Jones LONDON (Reuters) - Wall Street was headed lower on Wednesday, taking its cue from weaker global shares after U.S. Treasuries were pummelled on the prospect of the Federal Reserve firing on all cylinders next month to quell inflation. Investors also waited for details of the latest package of coordinated sanctions on Russia from the United States and its allies over civilian killings in Ukraine. The dollar hit its highest in almost two years, while expectations of new sanctions raised oil supply concerns to send crude prices higher. S&P500 futures were down 0.9%, with tech-heavy Nasdaq futures off 1.6%, pointing to a second day of selling. The CBOE Volatility index, widely dubbed Wall Street's fear index, rose to 23.25 points, up 10.5%. The MSCI All-Country stock index shed 0.5% as shares fell in Asia and Europe, after Fed Governor Lael Brainard said overnight she expected a combination of interest rate rises and a rapid balance sheet runoff to take U.S. monetary policy to a "more neutral position" later this year. Randy Kroszner, a former Fed Governor and now an economics professor at the University of Chicago Booth School of Business, said the Fed was right to act now while longer-term inflation expectations remained anchored. "Given that we've had significant 8% inflation and it's likely to persist for quite some time, longer-term inflation expectations have not yet become unanchored," Kroszner said. "So, they (Fed policymakers) have the opportunity to maintain credibility, but they need to act boldly and that means rapid rate increases, that means a more rapid winding down of the balance sheet than they would have wanted to do." The focus of investors on Wednesday will be on the release of minutes from the Fed's last policy meeting, out at 1800 GMT. "The minutes will be important for two main reasons. First, for clues on the likelihood of a 50 basis point hike, and what the committee would need to see to warrant a faster pace of hikes," analysts at UniCredit said in a note to clients. RECESSION RISK The gap between 2 and 10-year bond yields was at almost 5 basis points. This closely-watched part of the U.S. yield curve, viewed as a good indicator of recession risk, had been inverted for much of the past week. The yield on benchmark 10-year Treasury notes rose to 2.625%, hitting a three-year high after Brainard's remarks. The U.S. 2-year yield rose to its highest level since January 2019 and the 5-year yield to its highest since December 2018. [US/] DOLLAR HITS 2-YEAR HIGH The dollar index hit 99.386 after reaching its highest since late May 2020 in early trade. The euro was slightly firmer at $1.0923. The greenback was also trading firm against the yen at 123.80 yen given the Bank of Japan's conviction and repeated action last week to hold the yield on 10-year Japanese government bonds below 0.25%. Grace Peters, EMEA head of investment strategy at JPMorgan (NYSE:JPM) Private Bank, said 2022 was probably the last year of above-trend economic growth. "We are seeing Fed policy rapidly moving into restrictive territory. But we don't need to ditch equities, it just means we need to be more risk aware. At this point I would buy the dips but move into higher-quality assets," Peters said. "Markets see the curve inversion as the clock ticking down to the next recession. But it can be up to two years until recession hits and over that period stocks generally see a double-digit upside," she said. CRUDE GAINS The rise in bond yields globally has put pressure on gold, which pays no return. Spot gold slightly weaker at $1,923 per ounce. [GOL/] Oil prices recovered from early losses as the threat of new sanctions on Russia raised supply concerns, but there were fears of weaker demand following an increase in U.S. crude stockpiles and Shanghai's extended lockdown. U.S. crude was up 0.9% at $102.75 a barrel. Brent crude gained 0.5% to $107.20 per barrel. [O/R] In Asia, Hong Kong's Hang Seng index lost 1.8% on its return from a holiday, moving away from a one-month high reached on Monday, Chinese blue chips lost 0.3%. Japan's Nikkei shed 1.6%, while the MSCI's broadest index of Asia-Pacific shares outside Japan skidded 1.3%.
140 Replies 10 👍 14 🔥
they definitely have the cash > @bronco said: The article above @dros posted is your sign! Cue the board authorization for stock buyback PR.
104 Replies 9 👍 8 🔥
The article above @dros posted is your sign! Cue the board authorization for stock buyback PR.
108 Replies 7 👍 6 🔥
Indonesian regulator takes cue from Islamic NGOs, bars crypto sales for institutions https://cointelegraph.com/news/indonesian-regulator-takes-cue-from-islamic-ngos-bars-crypto-sales-for-institutions
82 Replies 13 👍 8 🔥
**@Bitboy_Crypto:** Right on cue https://t.co/SiwQIWclQc https://twitter.com/Bitboy_Crypto/status/1469025916265414664
50 Replies 6 👍 15 🔥
nice work > @sperry said: This CUE trade is turning out well. What a clear case of insider trading :)
134 Replies 14 👍 12 🔥
This CUE trade is turning out well. What a clear case of insider trading :)
120 Replies 8 👍 9 🔥
CUE on other hand majority of calls at/near ask
78 Replies 6 👍 13 🔥
The CUE calls from yesterday up ~12%
74 Replies 14 👍 13 🔥
93 Replies 14 👍 11 🔥
oh you talking about CUE
134 Replies 9 👍 11 🔥
Anyone following that CUE flow?
61 Replies 6 👍 14 🔥
“During our more optimistic years, we explored what could go wrong for stocks in our ‘Exploring the Dark Side’ series, but with our now tepid outlook for flat returns through 2022, we take our cue from Monty Python and look on the bright side,” Subramanian wrote, in a recent update, adding that although record equity duration leaves stocks extremely vulnerable to a sharp rise in yields, the corollary is that lower rates could translate into lots of upside. “A rising discount rate is more negative than ever — a 1ppt increase in the cost of equity could drive the S&P 500 to ~3600, but conversely, a 1ppt drop would push the S&P 500 to 6300,” Subramanian said, pointing out that “convexity matters here, as risks are asymmetric.”
119 Replies 10 👍 11 🔥
I will cue up the tumbleweed pics then
105 Replies 9 👍 14 🔥
Wow, right on cue. Quad 4 M&A
80 Replies 14 👍 10 🔥
Right on cue! 🤐
56 Replies 15 👍 7 🔥
right on cue
50 Replies 12 👍 12 🔥
right on cue
58 Replies 8 👍 14 🔥
Right on Cue, it's Broccoli
87 Replies 14 👍 12 🔥
Then, watch the tape for confirmation. Is the volume now fading post exhaustion move? Yes, demand is gone. That's my cue
121 Replies 13 👍 12 🔥
Brexit and the announcement of a new 'mutant' strain of the virus have been enough to upend the markets although the latter is perhaps not quite as 'new' as first thought. Cue collapse of gbp & the indices no doubt helped along with the 5.6% fall in Tesla in the premarket which btw opens at 4.00 am EST (9.00 am London). Wall Street should be interesting given a $900bn rescue package has now been agreed upon. This combination of dramatic news & falling liquidity is a recipe for a roller coaster ride as volatility to go into overdrive so don't expect to stay in too long & keep your stops tight.
81 Replies 14 👍 8 🔥
Ha! Right on cue!
134 Replies 14 👍 15 🔥
lol right on cue, Russian State Media ZeroHedge is calling MI vote a fraud
100 Replies 6 👍 11 🔥
false break so far on cue
87 Replies 11 👍 7 🔥
Today it’s positive. European equities took the cue from a strong Asian session and pushed higher on Monday morning, with the narrative centering on treatment and vaccine news. Donald Trump is said to be mulling fast-tracking AstraZeneca’s vaccine candidate, whilst the FDA issued an emergency use authorisation for using plasma from recovered patients to treat Covid-19. Shares in Astra rose 2 per cent in early trade. Meanwhile, the US and EU have struck a ‘mini’ deal to cut tariffs on a range of items, which marks an important de-escalation of trade tensions that has dogged relations for many months.
131 Replies 8 👍 12 🔥
might be my cue
51 Replies 14 👍 6 🔥
The S&P 500 flirted with 3,400 in the early part of Wednesday’s session but shot 50pts lower after the minutes were released, ending down 0.44 per cent to 3,374.85. The Dow and Nasdaq both tripped up as well. Asian markets fell overnight. European equity indices are taking their cue from this weak handover and dropped over 1 per cent in early trade, before stocks pulled off the lows after China’s ministry of commerce said this morning that US-China trade talks would resume in the coming days. Vix futures are still pointing to increased volatility as we head towards the US election in November.
104 Replies 8 👍 11 🔥
Never mind all that for now though, stocks keep going up. The S&P 500 rose 1.4 per cent to end at 3,380, just six points under its record closing high at 3,386.15, with the record intraday peak at 3,393.52. Asian stocks broadly followed through, with shares in Tokyo up almost 2 per cent. European stocks failed to take the cue and were a little soft on the open, with the FTSE 100 the laggard at -1 per cent, though 22.3pts are due to BP, Shell, Diageo, AstraZeneca, GSK and Legal & General among others going ex-dividend.
111 Replies 7 👍 6 🔥
Right on cue with vaccine headlines. None of the articles see approval before next spring.
63 Replies 8 👍 13 🔥
no but that flow was my cue
111 Replies 8 👍 6 🔥
The S&P 500 rallied 0.5 per cent to move to the 61.8 per cent retracement, whilst the Nasdaq Composite set a new record high. The Dow finished a little lower. Shares in Asia took the cue to rally, whilst European bourses have opened with strength on Thursday morning. Lots of noise around but equity markets are not showing any real trend - major indices are still sitting around the middle of the June ranges.
59 Replies 8 👍 12 🔥
Next Earnings Date
Next Dividend Date
Cue Biopharma, a clinical-stage biopharmaceutical company, is engineering a novel class of injectable biologics to selectively engage and modulate targeted T cells directly within the patient's body to transform the treatment of cancer, infectious diseases and autoimmune diseases. The company's proprietary platform, Immuno-STAT ™(Selective Targeting and Alteration of T cells) is designed to harness the body's intrinsic immune system without the need for ex vivo manipulation.
CEO: Daniel Passeri
HQ: 21 Erie St Cambridge, 02139-4260 Massachusetts